Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Advisory Board
Pipeline
Overview
XRx-026 for Gout
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
225 for Type 2 Diabetic Nephropathy
Publications
Technology
News & Media
Press Releases
Events
In the News
Investors
Overview
News & Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
LIFE Offering
SEDAR+
Governance
Contact
Press Releases
News & Media
News & Media
Press Releases
Events
In the News
Year
All Years
2025
2024
2023
2022
2021
2020
2019
2018
Jan 17, 2025 5:00pm EST
XORTX Announces Change of Auditor
Jan 06, 2025 7:00am EST
XORTX Adds Late Stage Gout Program to Pipeline
arrow_back
1
2
rss_feed
News RSS